.

Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Army
Johnson and Johnson
Healthtrust
Fuji
QuintilesIMS
Queensland Health
Covington
Fish and Richardson
Farmers Insurance
Teva

Generated: November 23, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 018874

« Back to Dashboard
NDA 018874 describes CALCIJEX, which is a drug marketed by Abbvie and is included in one NDA. There are three patents protecting this drug. Additional details are available on the CALCIJEX profile page.

The generic ingredient in CALCIJEX is calcitriol. There are ten drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the calcitriol profile page.

Summary for 018874

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:3
Formulation / Manufacturing:see details

Medical Subject Heading (MeSH) Categories for 018874

Summary for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength0.001MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:Sep 25, 1986TE:RLD:Yes
Patent:► SubscribePatent Expiration:Feb 2, 2020Product Flag?Substance Flag?Delist Request?Y
Patent:► SubscribePatent Expiration:Feb 2, 2020Product Flag?Substance Flag?Delist Request?Y
Patent:► SubscribePatent Expiration:Feb 2, 2020Product Flag?Substance Flag?Delist Request?Y

Expired Orange Book Patents for NDA: 018874

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Abbvie
CALCIJEX
calcitriol
INJECTABLE;INJECTION018874-001Sep 25, 1986► Subscribe► Subscribe
Abbvie
CALCIJEX
calcitriol
INJECTABLE;INJECTION018874-002Sep 25, 1986► Subscribe► Subscribe
Abbvie
CALCIJEX
calcitriol
INJECTABLE;INJECTION018874-002Sep 25, 1986► Subscribe► Subscribe
Abbvie
CALCIJEX
calcitriol
INJECTABLE;INJECTION018874-001Sep 25, 1986► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Deloitte
Harvard Business School
McKinsey
Cerilliant
Queensland Health
Julphar
UBS
McKesson
Colorcon
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot